{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T16:42:59Z","timestamp":1778863379102,"version":"3.51.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,28]],"date-time":"2018-06-28T00:00:00Z","timestamp":1530144000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003715","name":"Korea Research Institute of Bioscience and Biotechnology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003715","id-type":"DOI","asserted-by":"publisher"}]},{"name":"INNOPOLOS foundation of the Republic of Korea"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12967-018-1546-z","type":"journal-article","created":{"date-parts":[[2018,6,28]],"date-time":"2018-06-28T11:25:49Z","timestamp":1530185149000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Identification of anti-SF3B1 autoantibody as a diagnostic marker in patients with hepatocellular carcinoma"],"prefix":"10.1186","volume":"16","author":[{"given":"Hai-Min","family":"Hwang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Kyu","family":"Heo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hye Jung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Seob","family":"Kwak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Won-Hee","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong-Shin","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dae-Yuel","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kook Jin","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeong-Yoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0528-7528","authenticated-orcid":false,"given":"Eun-Wie","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,6,28]]},"reference":[{"key":"1546_CR1","unstructured":"World Health Organization. Guide to cancer early diagnosis. 2017. http:\/\/www.who.int\/cancer\/publications\/cancer . Accessed 10 Mar 2018."},{"key":"1546_CR2","doi-asserted-by":"publisher","first-page":"513","DOI":"10.3390\/diagnostics5040513","volume":"5","author":"C Schraml","year":"2015","unstructured":"Schraml C. Imaging of HCC-current state of the art. Diagnostics (Basel). 2015;5:513\u201345.","journal-title":"Diagnostics (Basel)."},{"key":"1546_CR3","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/978-94-017-7215-0_3","volume":"867","author":"MJ Duffy","year":"2015","unstructured":"Duffy MJ. Use of biomarkers in screening for cancer. Adv Exp Med Biol. 2015;867:27\u201339.","journal-title":"Adv Exp Med Biol"},{"key":"1546_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.201600442","author":"E Meeusen","year":"2017","unstructured":"Meeusen E, Lim E, Mathivanan S. Secreted tumor antigens\u2014immune biomarkers for diagnosis and therapy. Proteomics. 2017. https:\/\/doi.org\/10.1002\/pmic.201600442 .","journal-title":"Proteomics"},{"key":"1546_CR5","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s13045-017-0542-8","volume":"10","author":"A Li","year":"2017","unstructured":"Li A, Zhang T, Zheng M, Liu Y, Chen Z. Exosomal proteins as potential markers of tumor diagnosis. J Hematol Oncol. 2017;10:175.","journal-title":"J Hematol Oncol."},{"key":"1546_CR6","first-page":"30474","volume":"pii: S1084\u20139521","author":"K Kai","year":"2017","unstructured":"Kai K, Dittmar RL, Sen S. Secretory microRNAs as biomarkers of cancer. Semin Cell Dev Biol. 2017;pii: S1084\u20139521:30474\u201383.","journal-title":"Semin Cell Dev Biol"},{"key":"1546_CR7","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.trecan.2017.02.003","volume":"3","author":"IK Macdonald","year":"2017","unstructured":"Macdonald IK, Parsy-Kowalska CB, Chapman CJ. Autoantibodies: opportunities for early cancer detection. Trends Cancer. 2017;3:198\u2013213.","journal-title":"Trends Cancer."},{"key":"1546_CR8","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1158\/1055-9965.EPI-13-0621","volume":"22","author":"P Zaenker","year":"2013","unstructured":"Zaenker P, Ziman MR. Serologic autoantibodies as diagnostic cancer biomarkers\u2014a review. Cancer Epidemiol Biomarkers Prev. 2013;22:2161\u201381.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1546_CR9","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/1479-5876-12-121","volume":"12","author":"J Mao","year":"2014","unstructured":"Mao J, Ladd J, Gad E, Rastetter L, Johnson MM, Marzbani E, Childs JS, Lu H, Dang Y, Broussard E, Stanton SE, Hanash SM, Disis ML. Mining the pre-diagnostic antibody repertoire of TgMMTV-neu mice to identify autoantibodies useful for the early detection of human breast cancer. J Transl Med. 2014;12:121.","journal-title":"J Transl Med."},{"key":"1546_CR10","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1021\/pr0500814","volume":"4","author":"KS Anderson","year":"2005","unstructured":"Anderson KS, LaBaer J. The sentinel within: exploiting the immune system for cancer biomarkers. J Proteome Res. 2005;4:1123\u201333.","journal-title":"J Proteome Res"},{"key":"1546_CR11","doi-asserted-by":"publisher","first-page":"45846","DOI":"10.1038\/srep45846","volume":"7","author":"MC Wong","year":"2017","unstructured":"Wong MC, Jiang JY, Goggins WB, Liang M, Fang Y, Fung FD, Leung C, Wang HH, Wong GL, Wong VW, Chan HL. International incidence and mortality trends of liver cancer: a global profile. Sci Rep. 2017;7:45846.","journal-title":"Sci Rep."},{"key":"1546_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.cca.2008.05.010","volume":"395","author":"EN Debruyne","year":"2008","unstructured":"Debruyne EN, Delanghe JR. Diagnosing and monitoring hepatocellular carcinoma with alpha-fetoprotein: new aspects and applications. Clin Chim Acta. 2008;395:19\u201326.","journal-title":"Clin Chim Acta"},{"key":"1546_CR13","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cca.2016.10.006","volume":"463","author":"C Sauzay","year":"2016","unstructured":"Sauzay C, Petit A, Bourgeois AM, Barbare JC, Chauffert B, Galmiche A, Houessinon A. Alpha-foetoprotein (AFP): a multi-purpose marker in hepatocellular carcinoma. Clin Chim Acta. 2016;463:39\u201344.","journal-title":"Clin Chim Acta"},{"key":"1546_CR14","first-page":"182","volume":"11","author":"XD Zhang","year":"2014","unstructured":"Zhang XD, Wang Y, Ye LH. Hepatitis B virus X protein accelerates the development of hepatoma. Cancer Biol Med. 2014;11:182\u201390.","journal-title":"Cancer Biol Med."},{"key":"1546_CR15","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0168-8278(99)80172-X","volume":"31","author":"DY Yu","year":"1999","unstructured":"Yu DY, Moon HB, Son JK, Jeong S, Yu SL, Yoon H, Han YM, Lee CS, Park JS, Lee CH, Hyun BH, Murakami S, Lee KK. Incidence of hepatocellular carcinoma in transgenic mice expressing the hepatitis B virus X-protein. J Hepatol. 1999;31:123\u201332.","journal-title":"J Hepatol"},{"key":"1546_CR16","doi-asserted-by":"crossref","first-page":"68044","DOI":"10.18632\/oncotarget.11172","volume":"7","author":"B Han","year":"2016","unstructured":"Han B, Shin HJ, Bak IS, Bak Y, Jeong YL, Kwon T, Park YH, Sun HN, Kim CH, Yu DY. Peroxiredoxin I is important for cancer-cell survival in Ras-induced hepatic tumorigenesis. Oncotarget. 2016;7:68044\u201356.","journal-title":"Oncotarget."},{"key":"1546_CR17","doi-asserted-by":"crossref","first-page":"56944","DOI":"10.18632\/oncotarget.10922","volume":"7","author":"HL Ha","year":"2016","unstructured":"Ha HL, Kwon T, Bak IS, Erikson RL, Kim BY, Yu DY. IGF-II induced by hepatitis B virus X protein regulates EMT via SUMO mediated loss of E-cadherin in mice. Oncotarget. 2016;7:56944\u201357.","journal-title":"Oncotarget."},{"key":"1546_CR18","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.bbrc.2015.09.082","volume":"466","author":"Y Bak","year":"2015","unstructured":"Bak Y, Shin HJ, Bak I, Yoon DY, Yu DY. Hepatitis B virus X promotes hepatocellular carcinoma development via nuclear protein 1 pathway. Biochem Biophys Res Commun. 2015;466:676\u201381.","journal-title":"Biochem Biophys Res Commun"},{"key":"1546_CR19","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.bbrc.2013.04.071","volume":"435","author":"YH Park","year":"2013","unstructured":"Park YH, Shin HJ, Kim SU, Kim JM, Kim JH, Bang DH, Chang KT, Kim BY, Yu DY. iNOS promotes HBx-induced hepatocellular carcinoma via upregulation of JNK activation. Biochem Biophys Res Commun. 2013;435:244\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"1546_CR20","doi-asserted-by":"publisher","first-page":"5912","DOI":"10.1158\/0008-5472.CAN-12-2329","volume":"72","author":"A Arzumanyan","year":"2012","unstructured":"Arzumanyan A, Sambandam V, Clayton MM, Choi SS, Xie G, Diehl AM, Yu DY, Feitelson MA. Hedgehog signaling blockade delays hepatocarcinogenesis induced by hepatitis B virus X protein. Cancer Res. 2012;72:5912\u201320.","journal-title":"Cancer Res"},{"key":"1546_CR21","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.canlet.2010.09.018","volume":"300","author":"A Hsieh","year":"2011","unstructured":"Hsieh A, Kim HS, Lim SO, Yu DY, Jung G. Hepatitis B viral X protein interacts with tumor suppressor adenomatous polyposis coli to activate Wnt\/\u03b2-catenin signaling. Cancer Lett. 2011;300:162\u201372.","journal-title":"Cancer Lett"},{"key":"1546_CR22","doi-asserted-by":"publisher","first-page":"4932","DOI":"10.3748\/wjg.v16.i39.4932","volume":"16","author":"HL Ha","year":"2010","unstructured":"Ha HL, Yu DY. HBx-induced reactive oxygen species activates hepatocellular carcinogenesis via dysregulation of PTEN\/Akt pathway. World J Gastroenterol. 2010;16:4932\u20137.","journal-title":"World J Gastroenterol"},{"key":"1546_CR23","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.jmb.2010.02.016","volume":"397","author":"JY Kim","year":"2010","unstructured":"Kim JY, Song EH, Lee HJ, Oh YK, Choi KH, Yu DY, Park SI, Seong JK, Kim WH. HBx-induced hepatic steatosis and apoptosis are regulated by TNFR1- and NF-kappaB-dependent pathways. J Mol Biol. 2010;397:917\u201331.","journal-title":"J Mol Biol"},{"key":"1546_CR24","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1053\/j.gastro.2007.03.039","volume":"132","author":"KH Kim","year":"2007","unstructured":"Kim KH, Shin HJ, Kim K, Choi HM, Rhee SH, Moon HB, Kim HH, Yang US, Yu DY, Cheong J. Hepatitis B virus X protein induces hepatic steatosis via transcriptional activation of SREBP1 and PPARgamma. Gastroenterology. 2007;132:1955\u201367.","journal-title":"Gastroenterology"},{"key":"1546_CR25","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1159\/000082090","volume":"48","author":"JS Koo","year":"2005","unstructured":"Koo JS, Seong JK, Park C, Yu DY, Oh BK, Oh SH, Park YN. Large liver cell dysplasia in hepatitis B virus X transgenic mouse liver and human chronic hepatitis B virus-infected liver. Intervirology. 2005;48:16\u201322.","journal-title":"Intervirology"},{"key":"1546_CR26","doi-asserted-by":"publisher","first-page":"15460","DOI":"10.1074\/jbc.M309280200","volume":"279","author":"YI Lee","year":"2004","unstructured":"Lee YI, Hwang JM, Im JH, Lee YI, Kim NS, Kim DG, Yu DY, Moon HB, Park SK. Human hepatitis B virus-X protein alters mitochondrial function and physiology in human liver cells. J Biol Chem. 2004;279:15460\u201371.","journal-title":"J Biol Chem"},{"key":"1546_CR27","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1096\/fj.03-0153fje","volume":"18","author":"EJ Moon","year":"2004","unstructured":"Moon EJ, Jeong CH, Jeong JW, Kim KR, Yu DY, Murakami S, Kim CW, Kim KW. Hepatitis B virus X protein induces angiogenesis by stabilizing hypoxia-inducible factor-1alpha. FASEB J. 2004;18:382\u20134.","journal-title":"FASEB J."},{"key":"1546_CR28","first-page":"1453","volume":"36","author":"CK Heo","year":"2010","unstructured":"Heo CK, Woo MK, Yu DY, Lee JY, Yoo JS, Yoo HS, Ko JH, Kim JM, Choi JY, Kim IG, Paik SG, Cho EW. Identification of autoantibody against fatty acid synthase in hepatocellular carcinoma mouse model and its application to diagnosis of HCC. Int J Oncol. 2010;36:1453\u20139.","journal-title":"Int J Oncol"},{"key":"1546_CR29","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.jhep.2005.04.012","volume":"43","author":"AG Wang","year":"2005","unstructured":"Wang AG, Moon HB, Lee MR, Hwang CY, Kwon KS, Yu SL, Kim YS, Kim M, Kim JM, Kim SK, Lee TH, Moon EY, Lee DS, Yu DY. Gender-dependent hepatic alterations in H-ras12V transgenic mice. J Hepatol. 2005;43:836\u201344.","journal-title":"J Hepatol"},{"key":"1546_CR30","doi-asserted-by":"publisher","first-page":"27031","DOI":"10.3402\/jev.v4.27031","volume":"4","author":"RJ Lobb","year":"2015","unstructured":"Lobb RJ, Becker M, Wen Wen S, Wong CS, Wiegmans AP, Leimgruber A, M\u00f6ller A. Optimized exosome isolation protocol for cell culture supernatant and human plasma. J Extracell Vesicles. 2015;4:27031.","journal-title":"J Extracell Vesicles."},{"key":"1546_CR31","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3892\/ijo.2012.1679","volume":"42","author":"CK Heo","year":"2013","unstructured":"Heo CK, Hwang HM, Ruem A, Yu DY, Lee JY, Yoo JS, Kim IG, Yoo HS, Oh S, Ko JH, Cho EW. Identification of a mimotope for circulating anti-cytokeratin 8\/18 antibody and its usage for the diagnosis of breast cancer. Int J Oncol. 2013;42:65\u201374.","journal-title":"Int J Oncol"},{"key":"1546_CR32","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1007\/s003350010258","volume":"12","author":"K Isono","year":"2001","unstructured":"Isono K, Abe K, Tomaru Y, Okazaki Y, Hayashizaki Y, Koseki H. Molecular cloning, genetic mapping, and expression of the mouse Sf3b1 (SAP155) gene for the U2 snRNP component of spliceosome. Mamm Genome. 2001;12:192\u20138.","journal-title":"Mamm Genome"},{"key":"1546_CR33","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1182\/blood-2017-03-776070","volume":"130","author":"T Mortera-Blanco","year":"2017","unstructured":"Mortera-Blanco T, Dimitriou M, Woll PS, Karimi M, Elvarsdottir E, Conte S, Tobiasson M, Jansson M, Douagi I, Moarii M, Saft L, Papaemmanuil E, Jacobsen SEW, Hellstr\u00f6m-Lindberg E. SF3B1-initiating mutations in MDS-RSs target lymphomyeloid hematopoietic stem cells. Blood. 2017;130:881\u201390.","journal-title":"Blood"},{"key":"1546_CR34","doi-asserted-by":"crossref","first-page":"115018","DOI":"10.18632\/oncotarget.22983","volume":"8","author":"X Fu","year":"2017","unstructured":"Fu X, Tian M, Gu J, Cheng T, Ma D, Feng L, Xin X. SF3B1 mutation is a poor prognostic indicator in luminal B and progesterone receptor-negative breast cancer patients. Oncotarget. 2017;8:115018\u201327.","journal-title":"Oncotarget."},{"key":"1546_CR35","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/modpathol.2017.23","volume":"30","author":"KG Griewank","year":"2017","unstructured":"Griewank KG, M\u00fcller H, Jackett LA, Emberger M, M\u00f6ller I, van de Nes JA, Zimmer L, Livingstone E, Wiesner T, Scholz SL, Cosgarea I, Sucker A, Schimming T, Hillen U, Schilling B, Paschen A, Reis H, Mentzel T, Kutzner H, R\u00fctten A, Murali R, Scolyer RA, Schadendorf D. SF3B1 and BAP1 mutations in blue nevus-like melanoma. Mod Pathol. 2017;30:928\u201339.","journal-title":"Mod Pathol"},{"key":"1546_CR36","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.cell.2017.05.046","volume":"169","author":"Cancer Genome Atlas Research Network","year":"2017","unstructured":"Cancer Genome Atlas Research Network. Comprehensive and integrative genomic characterization of hepatocellular carcinoma. Cell. 2017;169:1327\u201341. https:\/\/doi.org\/10.1016\/j.cell.2017.05.046 .","journal-title":"Cell."},{"key":"1546_CR37","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1038\/onc.2016.279","volume":"36","author":"AK Kesarwani","year":"2017","unstructured":"Kesarwani AK, Ramirez O, Gupta AK, Yang X, Murthy T, Minella AC, Pillai MM. Cancer-associated SF3B1 mutants recognize otherwise inaccessible cryptic 3\u2032 splice sites within RNA secondary structures. Oncogene. 2017;36:1123\u201333.","journal-title":"Oncogene"},{"key":"1546_CR38","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.autrev.2016.01.017","volume":"15","author":"P Zaenker","year":"2016","unstructured":"Zaenker P, Gray ES, Ziman MR. Autoantibody production in cancer-the humoral immune response toward autologous antigens in cancer patients. Autoimmun Rev. 2016;15:477\u201383.","journal-title":"Autoimmun Rev"},{"key":"1546_CR39","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ymeth.2015.04.008","volume":"87","author":"R Xu","year":"2015","unstructured":"Xu R, Greening DW, Rai A, Ji H, Simpson RJ. Highly-purified exosomes and shed microvesicles isolated from the human colon cancer cell line LIM1863 by sequential centrifugal ultrafiltration are biochemically and functionally distinct. Methods. 2015;87:11\u201325.","journal-title":"Methods"},{"key":"1546_CR40","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jprot.2012.12.029","volume":"80","author":"B Liang","year":"2013","unstructured":"Liang B, Peng P, Chen S, Li L, Zhang M, Cao D, Yang J, Li H, Gui T, Li X, Shen K. Characterization and proteomic analysis of ovarian cancer-derived exosomes. J Proteomics. 2013;80:171\u201382.","journal-title":"J Proteomics."},{"key":"1546_CR41","doi-asserted-by":"publisher","first-page":"3849","DOI":"10.1073\/pnas.071042298","volume":"98","author":"J Eilbracht","year":"2001","unstructured":"Eilbracht J, Schmidt-Zachmann MS. Identification of a sequence element directing a protein to nuclear speckles. Proc Natl Acad Sci USA. 2001;98:3849\u201354.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1546_CR42","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.tig.2017.03.001","volume":"33","author":"JL Jenkins","year":"2017","unstructured":"Jenkins JL, Kielkopf CL. Splicing Factor Mutations in Myelodysplasias: Insights from Spliceosome Structures. Trends Genet. 2017;33:336\u201348.","journal-title":"Trends Genet."},{"key":"1546_CR43","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s12885-017-3175-y","volume":"17","author":"FM Sullivan","year":"2017","unstructured":"Sullivan FM, Farmer E, Mair FS, Treweek S, Kendrick D, Jackson C, Robertson C, Briggs A, McCowan C, Bedford L, Young B, Vedhara K, Gallant S, Littleford R, Robertson J, Sewell H, Dorward A, Sarvesvaran J, Schembri S. Detection in blood of autoantibodies to tumour antigens as a case-finding method in lung cancer using the EarlyCDT\u00ae-Lung Test (ECLS): study protocol for a randomized controlled trial. BMC Cancer. 2017;17:187.","journal-title":"BMC Cancer."},{"key":"1546_CR44","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1158\/1940-6207.CAPR-10-0328","volume":"4","author":"S Lam","year":"2011","unstructured":"Lam S, Boyle P, Healey GF, Maddison P, Peek L, Murray A, Chapman CJ, Allen J, Wood WC, Sewell HF, Robertson JF. EarlyCDT-Lung: an immunobiomarker test as an aid to early detection of lung cancer. Cancer Prev Res (Phila). 2011;4:1126\u201334.","journal-title":"Cancer Prev Res (Phila)."}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-018-1546-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12967-018-1546-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-018-1546-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T15:00:40Z","timestamp":1604502040000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-018-1546-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,28]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1546"],"URL":"https:\/\/doi.org\/10.1186\/s12967-018-1546-z","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,28]]},"assertion":[{"value":"5 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"177"}}